Literature DB >> 15223836

The link between LUTS and ED: clinical and basic science evidence.

Jonathan D Schiff1, John P Mulhall.   

Abstract

Mesh：

Year:  2004        PMID： 15223836     DOI： 10.1002/j.1939-4640.2004.tb02818.x

Source DB:  PubMed          Journal:  J Androl        ISSN： 0196-3635


× No keyword cloud information.
  7 in total

1.  Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms.

Authors:  Steven A Kaplan; Ricardo R Gonzalez
Journal:  Rev Urol       Date:  2007

Review 2.  Erectile Dysfunction and Lower Urinary Tract Symptoms.

Authors:  Cosimo De Nunzio; Riccardo Lombardo; Giorgia Tema; Andrea Tubaro
Journal:  Curr Urol Rep       Date:  2018-06-01       Impact factor: 3.092

Review 3.  Sexual dysfunction in the patient with prostatitis.

Authors:  Alexander Müller; John P Mulhall
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 4.  First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?

Authors:  Ricardo R Gonzalez; Steven A Kaplan
Journal:  World J Urol       Date:  2006-05-19       Impact factor: 4.226

5.  The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Yunus Doğan; Fatih Uruç; Bekir Aras; Aytaç Şahin; Mithat Kıvrak; Ahmet Ürkmez; Numan Doğu Güner; Sabahattin Aydın
Journal:  Turk J Urol       Date:  2015-03

6.  A prospective study of lower urinary tract symptoms and erectile dysfunction.

Authors:  Alison M Mondul; Eric B Rimm; Edward Giovannucci; Dale B Glasser; Elizabeth A Platz
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

7.  The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.

Authors:  Asim Ozayar; Ali Ersin Zumrutbas; Onder Yaman
Journal:  Int Urol Nephrol       Date:  2008-04-24       Impact factor: 2.370
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.